Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease
Yunguang Qiu(Cleveland Clinic Lerner College of Medicine), Feixiong Cheng(Cleveland Clinic Lerner College of Medicine), Andrew A. Pieper(Cornell University), Yadi Zhou(Cleveland Clinic Lerner College of Medicine), Yuxin Yang(Cleveland Clinic), Marina Bykova(Cleveland Clinic Lerner College of Medicine), Ruth Nussinov(Frederick National Laboratory for Cancer Research), Dhruv Gohel(Maharaja Sayajirao University of Baroda), J Mark Brown(Cleveland Clinic Lerner College of Medicine), Jielin Xu(Cleveland Clinic Lerner College of Medicine), Yuan Hou(Cleveland Clinic Lerner College of Medicine), James B Leverenz(Cleveland Clinic Lerner College of Medicine), Jessica Caldwell(University of Wisconsin–Madison)
Cited by 36
Related Papers
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
|BMC Medicine|2020|458
Alzheimer's disease drug development pipeline: 2023
|Alzheimer s & Dementia Translational Research & Clinical Interventions|2023|457
SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents
|Cell Metabolism|2015|428
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
|Cell Reports|2018|396
Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity
|Journal of Chemical Information and Modeling|2019|218